Ibogaine treatment for Orlando residents: the physician-prescribed pathway through Brazil

Ibogaine is a Schedule I controlled substance in the United States. No clinic, hospital, or physician in Florida can legally prescribe or administer it. That policy gap is not closing soon, even as Texas, Colorado, Oklahoma, and other states advance ibogaine research legislation.

Florida has not passed a bill funding or authorizing ibogaine clinical trials. The Americans for Ibogaine state legislation tracker has identified Florida as a state of interest for joining a multi-state research collaboration alongside Texas, but no Florida bill has been introduced or passed as of June 2026. The April 2026 Executive Order on ibogaine research — with a specific focus on veterans — matters in Orlando, home to Naval Support Activity Orlando and a substantial military community. It does not create treatment access today.

Florida's treatment landscape carries unusual weight for families considering ibogaine. Lax regulation in the 2010s turned South Florida into the so-called rehab capital of the United States — the Florida shuffle pattern of cycling through for-profit programs. Florida's 2017 Patient Brokering Act and the 2018 federal Eliminating Kickbacks in Recovery Act tightened oversight, and the state saw meaningful overdose declines — but the recurring-relapse dynamic those years created shapes how many Floridians arrive at this conversation.

Orange County's fentanyl toll makes the stakes concrete. Accidental overdose deaths peaked at 538 in 2021; opioid-related deaths fell from 453 that year to 229 in 2024 — a nearly 50% decline. Even after a 30% drop from 2023 to 2024, 341 deaths in a single county is still a crisis. Orlando sits at the heart of the I-4 corridor, where counterfeit fentanyl pills have displaced prescription opioids across Orange, Osceola, and Seminole counties. Polysubstance use — fentanyl with cocaine or methamphetamine — drives many of the deaths the Medical Examiners Commission documents.

If your loved one is in active addiction, you have probably heard a lot of clinical language that did not translate into results. Ibogaine is worth understanding differently, because it works differently.

Ibogaine is a naturally occurring compound derived from the root bark of the iboga plant. It acts on multiple receptor systems simultaneously, including opioid receptors, NMDA receptors, and serotonin pathways. The result, for many patients, is a dramatic reduction in acute opioid withdrawal symptoms and a reset of the neurological patterns that drive compulsive use. The full receptor-level mechanism is covered in detail on our ibogaine overview.

What makes ibogaine different from medication-assisted treatment goes beyond pharmacology. It is the window that opens after. In the weeks following a session, the brain enters a period of elevated neuroplasticity, sometimes called the Window of Wonder, that typically lasts 2 to 12 weeks. This is not a passive recovery period. It is the window that Nekawa's 15-day on-site integration and 45-day at-home coursework are specifically built around, because what a student does during that window shapes what the session becomes long-term.

Ibogaine is not appropriate for everyone. The peer-reviewed research is serious and growing, and so is the understanding of who is and is not a candidate. Cardiac history, current medications, and other health factors all matter. That is precisely why the physician-prescribed pathway requires a full medical workup before any session proceeds.

The ibogaine session at the heart of Nekawa's program is prescribed and administered by independent licensed Brazilian physicians, not by Nekawa. Understanding what that means in practice matters, because it is the difference between a supervised medical procedure and an unmonitored retreat experience.

Before the prescribing physicians clear a patient for ibogaine, the workup includes:

• EKG
• QT-interval check
• Comprehensive blood panel
• Liver function test
• Magnesium loading

The QT-interval check is the critical cardiac screen. Ibogaine affects cardiac conduction, and a prolonged QT interval is a contraindication. This is not a formality. It is the reason the medical workup exists.

During the session, an on-site physician is present throughout. The hospital's ICU-trained nursing team monitors continuous cardiac telemetry for a minimum of 24 hours post-dose. The session itself moves through distinct phases: the intense visionary phase lasts 6 to 12 hours, followed by roughly 12 hours of quieter mental processing, then 24 to 48 hours of physical recuperation.

Nekawa's role is not clinical. We build the preparation, the environment, and the integration structure around the medical team's work. The full program structure is:

• 10 days of preparation and on-site medical onboarding before the session
• The ibogaine session, administered by the medical team in a hospital setting with continuous cardiac telemetry
• 15 days of structured integration on the property
• 45 days of at-home integration coursework after returning home

Longer on-site programs of up to 90 days are available for students who want deeper transformation work. The 28-day structure is the foundation; the extended program builds on it.

See our cardiac safety overview for the full QT-interval, EKG, and screening protocol the prescribing physicians follow.

Mexico and Costa Rica have become common destinations for ibogaine, and some of the programs there are run by serious people. But the regulatory framework is not the same, and that difference matters when you are talking about a compound that requires continuous cardiac monitoring.

In Brazil, ibogaine is approved for medical use under ANVISA, Brazil's federal health agency, the equivalent of the FDA. Treatment is prescribed by licensed physicians and delivered within hospital infrastructure that includes emergency response capability. This is not a private villa. It is not a retreat center operating in a gray area. The current US and global legal status of ibogaine makes clear why the structure of the Brazilian system is distinct.

Nekawa is a wellness education academy, structured around the hospital infrastructure that physician-administered ibogaine treatment requires. We do not run the medical protocol. The prescribing physicians do. What we provide is the preparation curriculum, the environment, the integration coursework, and the program structure that gives the medical session its full context.

The distinction matters for Orlando students specifically. Central Florida families who have already tried conventional rehab — including programs that operated in the gray area before reform — are often looking for a framework with hospital infrastructure, cardiac telemetry, and physician oversight. That is what the Brazilian pathway provides, and it is what states like Texas are now funding research to study.

Orlando International (MCO) connects to São Paulo–Guarulhos (GRU) or Rio de Janeiro–Galeão (GIG) via one-stop service through Miami, Atlanta, or Houston. Total travel time typically runs 12 to 16 hours door to door, depending on connection length.

From either GRU or GIG, it is a 4-hour drive along the BR-101 coastal highway to Paraty, on Brazil's Costa Verde coast. We arrange private ground transport from the airport, so students arrive directly without navigating Brazilian transit or making connections.

What you arrive to is not a medical facility. Our location sits in the Atlantic rainforest, the Mata Atlântica, at the edge of the sea. Old-growth jungle. Waterfalls. A protected lagoon. A bay scattered with more than 300 forested islands. The colonial port town of Paraty is just outside. The environment is part of the program. The preparation and integration work we walk students through is designed to use the setting intentionally.

As of January 1, 2026, US travelers need an approved Brazilian eVisa to enter Brazil. Apply online at brazil.vfsevisa.com.

• Cost: US$80.90
• Processing time: about 72 hours
• Validity: 10 years, multiple entries of up to 90 days per stay
• Passport: US passport with at least 6 months of remaining validity

Our intake team walks every student through this during onboarding.

Florida is not Texas or Oklahoma. There is no state ibogaine research fund, no pilot program, and no bill in the legislature as of June 2026.

What Florida does have is a mature — and complicated — addiction treatment infrastructure. The state licenses hundreds of substance use disorder providers through the Department of Children and Families. Orange County's Office for a Drug-Free Community has deployed naloxone kits, fentanyl test strips, and jail-based MAT programs that contributed to the county's 30% overdose decline in 2024. Florida's 2024 Medical Examiners Commission report documented a 35% decrease in fentanyl-caused deaths statewide in 2024. Those public health gains are real.

They do not create ibogaine treatment access. Ibogaine remains Schedule I under federal law and under Florida's own controlled substance schedules. The Americans for Ibogaine legislative tracker lists Florida among the states where advocates hope to advance research participation — potentially leveraging opioid settlement funds and federal momentum from the April 2026 Executive Order — but nothing is enacted.

For an Orlando resident in active addiction in 2026, the practical reality is unchanged: no Florida provider can prescribe or administer ibogaine, and no domestic clinical trial pathway is available through state legislation. Florida recorded 4,999 provisional drug overdose deaths in 2024 per CDC NCHS data.

The ibogaine session is not the end of the program. It is closer to the beginning of the part that requires the most work.

The 45 days of at-home integration coursework that follow the on-site program are structured around the Window of Wonder, the 2 to 12 weeks of elevated neuroplasticity that follow the session. This is when the brain is most receptive to new patterns, and it is when the coursework is designed to be used. Students returning to Orlando — to a condo in Lake Nona, a house in Winter Park, or an apartment in Baldwin Park — return to the same environment where the patterns formed. The at-home coursework is built with that reality in mind, including the social networks, economic stressors, and triggers that make recovery in this city its own challenge.

Orange County's expanded naloxone distribution and jail-based MAT programs have contributed to declining overdose deaths. Integration is the complement on the other side of a medical session: structured reflection, specific practices, and ongoing engagement with the material from the preparation phase. Our team remains in contact with students through this period. The work continues.

For students with opioid dependence specifically, the opioid program page covers how the full curriculum is structured for that context. Students navigating burnout, depression, or anxiety alongside addiction may find the burnout and mental health program relevant as well.

The first step is a discovery call. This is a candidacy and program-fit conversation, not a sales call. We are looking at whether Nekawa's program is genuinely right for you or your loved one, and whether you are ready to do what the program requires.

On the call, we cover the program structure, the preparation curriculum, what the on-site experience involves, and what the at-home integration period looks like. We also talk honestly about who the program is not right for. Clinical screening is conducted separately by the prescribing physicians. What we assess is program fit, commitment, and readiness.

If the program is a fit, we move to intake, onboarding, and scheduling. Our intake team handles visa guidance, ground transport coordination, and preparation coursework. You do not navigate this alone.

To start, visit Book a discovery call. If you are an Orlando family member trying to understand whether this is the right path, the discovery call is the right place to begin.